New MarketScape Report from IDC Health Insights Evaluates Evolution of Health Information Exchange Platform Solutions

FRAMINGHAM, Mass.--(BUSINESS WIRE)--

A new IDC MarketScape report from IDC Health Insights highlights the rapid evolution of the health information exchange (HIE) market. The comprehensive study, IDC MarketScape: U.S. Health Information Exchange Platform Solutions 2012 Vendor Assessment (Doc #HI235816), provides an evaluation of 16 vendors that offer a platform solution for Health Information Exchange. IDC Health Insights defines a platform as having development tools, published APIs, education of technical staff, a broad ecosystem of partners, and professional services. Vendors evaluated for this report include: AT&T, AxSys Technology, Caradigm, Carefx, Certify Data Systems, Covisint, dbMotion, IBM, Infor, InterSystems Corp., Medicity, OptumInsight, Oracle, Orion Health, RelayHealth, and Verizon.

The health information exchange market continues to evolve with the focus shifting from connecting the ecosystem to exchange data and qualify for meaningful use incentives, to turning data into "actionable information" that enables emerging accountable care or collaborative care initiatives. This shift has lead to additional market consolidation among HIE vendors. Since the IDC Health Insights report Vendor Assessment: Industry Short List for Health Information Exchange Technologies was published two years ago (March 2010, Doc #HI222529), seven HIE vendors have been acquired or merged and new, nontraditional players have entered the market including payers and telecommunication companies.

"The IT requirements for health information organizations and evolving care delivery and reimbursement models are too extensive for any one vendor to satisfy," said Lynne Dunbrack, program director, Connected Health IT Strategies at IDC Health Insights. "To address the business and technical requirements of accountable care, in addition to providing core HIE technologies, vendors are responding by developing, partnering, or acquiring analytics, collaborative care, and patient engagement technologies."

Platform-as-a-service will increasingly play an important role in delivering HIE capabilities as vendors look to create an ecosystem of strategic partnerships. Platforms will evolve over time to meet the needs of customers and partners in the ecosystem, often through self development. In contrast, packaged solutions are designed to meet a very specific set of requirements. The IDC MarketScape vendor assessments for HIE technology are not all inclusive as there are other vendors that provide either a packaged or platform solution for HIE. Additional HIE vendors are covered in IDC MarketScape: U.S. Health Information Exchange Packaged Solutions 2012 Vendor Assessment (Doc #HI235830), which covers ten vendors that offer a packaged solution for HIE.

IDC MarketScape criteria selection, weightings, and vendor scores represent well-researched IDC judgment about the market and specific vendors. IDC analysts tailor the range of standard characteristics by which vendors are measured through structured discussions, surveys, and interviews with market leaders, participants and end users. Market weightings are based on user interviews, buyer surveys and the input of a review board of IDC experts in each market. IDC analysts base individual vendor scores, and ultimately vendor positions within the IDC MarketScape, on detailed surveys and interviews with the vendors, publicly available information and end-user experiences in an effort to provide an accurate and consistent assessment of each vendor's characteristics, behavior and capability.

For additional information about this study, or to arrange a one-on-one briefing with Lynne please contact Julie Crotty at 978-877-0053 or Julie@attunecommunications.com. Reports are available to qualified members of the media. For information on purchasing reports, contact insights@idc.com; reporters should email Julie@attunecommunications.com.

About IDC MarketScape

IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

About IDC Health Insights

IDC Health Insights assists health businesses and IT leaders, as well as the suppliers who serve them, in making more effective technology decisions by providing accurate, timely, and insightful fact-based research and consulting services. Staffed by senior analysts with decades of industry experience, our global research analyzes and advises on business and technology issues facing the payer, provider and life sciences industries. International Data Corporation (IDC) is the premier global provider of market intelligence, advisory services, and events for the information technology market. IDC is a subsidiary of IDG, the world’s leading technology, media, research, and events company. For more information, please visit www.idc-hi.com, email info@idc-hi.com, or call 508-935-4445. Visit the IDC Health Insights Community at http://idc-insights-community.com/health

View the original article here

Health Net Community Solutions Salutes Three Kern County Groups for Helping Build Healthier Communities

Thu, Jun 28, 2012, 8:12 AM EDT - U.S. Markets open in 1 hr 18 mins

Sorry, I could not read the content fromt this page.

View the original article here

Outcomes Health Information Solutions Launches MA365™, New Care Management Tool

Wed, Jun 20, 2012, 11:35 AM EDT - U.S. Markets close in 4 hrs 25 mins

Sorry, I could not read the content fromt this page.

View the original article here

Healthstat, Inc. Acquires Health Center Operations for 29 LivingWell Health Solutions Clients

Fri, Jun 15, 2012, 8:07 AM EDT - U.S. Markets open in 1 hr 23 mins

Sorry, I could not read the content fromt this page.

View the original article here

Streamline Health® Solutions Reports Q1 Results

CINCINNATI, June 7, 2012 /PRNewswire/ -- Streamline Health Solutions, Inc. (STRM) today announced financial results for the first quarter of fiscal year 2012, ended April 30, 2012.

Highlights for the quarter included:

Achieved net profit of $492,000;Adjusted EBITDA for first quarter 2012 was $1.7 million an increase of 172%  over first quarter 2011;Recurring maintenance revenues improved by 13% over the prior comparable quarter;Software as a service (SaaS) revenues for the quarter increased 22% over the prior comparable quarter, excluding $490,000 of incremental SaaS revenue from the acquired operations of Interpoint Partners;New sales bookings for the quarter were $4.4 million;Maintenance and SaaS contract renewals for the quarter were $3.1 million;Backlog at the end of the quarter was $31.4 million, which was a 78% increase from the first quarter of 2011;

Revenues for the three month period ended April 30, 2012, were $5,445,000; as compared to $4,140,000 in the comparable period of fiscal 2011.  The quarterly and year to date increase was primarily attributable to revenues provided by increases in recurring maintenance and SaaS revenues.

The former Interpoint Partners, LLC business, acquired in the fourth quarter of fiscal 2011, contributed an incremental $490,000 in SaaS revenue in the first quarter of fiscal 2012. Recurring revenues from SaaS (net of Interpoint incremental revenues) and maintenance increased $203,000 and $275,000, respectively. These increases are due to annual increases, expansion of services to current clients, and additional revenue from a client that has transitioned to a direct relationship with Streamline Health.

Operating expenses for the three-month period ending April 30, 2012 were $4,773,000, compared to $4,394,000 in the comparable prior year period; an increase of $379,000 or 9% over the prior year comparable period.

As a result, Streamline Health recorded an operating profit of $672,000 or $0.07 per fully diluted share, for the three month period ended April 30, 2012 compared with an operating loss of $254,000, or ($0.03) per fully diluted share, for the prior year comparable quarter. Adjusted EBITDA* (a non-GAAP measure) for the quarter ended April 30, 2012 was $1.7 million, or $0.17 per fully diluted common share, compared to $630,000, or $0.06 per fully diluted common share in the comparable prior year quarter. A reconciliation table is provided below.

New sales bookings for the fourth quarter were $4.4 million, primarily consisting of professional services, and software as a service contracts.  Maintenance and SaaS renewals or extensions were $3.1 million.

Backlog at April 30, 2012 was $31.4 million, compared with $27.4 million at January 31, 2012 and $17.7 million at April 30, 2011. The increase in the current backlog reflects significant new SaaS contract signings as well as current clients purchasing additional solutions.  Additions to backlog included a five year agreement with Boston Medical Center to extend the use of our business analytics and patient financial services solutions, a renewal for a new five year agreement with Bronx-Lebanon Hospital Center, which was also transitioned to a direct agreement with Streamline Health; and a new SaaS agreement with Einstein Healthcare Network to employ our OpportunityAnyWare, ARWare, and 835 DenialWare solutions.

Robert E. Watson, President and Chief Executive Officer of Streamline Health said, "The results for the quarter, by every financial metric, clearly highlight that we are making meaningful progress in our transition to a results oriented healthcare information technology company.  Needless to say, we are pleased with our progress.  This quarter was a significant step forward in the transition process that began some fifteen months ago."

Mr. Watson continued, "Continuing the trend noted in previous quarters, we are also pleased with the transition, completed during the quarter, of Bronx-Lebanon Hospital Center to a 'direct client' and the extension of their agreement with us for an additional five years.   Also during the quarter, Einstein Healthcare Network, a ten-year client of our AccessAnyWare solution, purchased our OpportunityAnyWare solution for their clinic operations.  This was the first purchase of the former Interpoint Partners' solution by a Streamline Health client.  Additionally, the purchase by Boston Medical Center of the OpportunityAnyWare solution for their clinics is an example of our team's ability to upsell additional solutions in our installed base of clients. In conjunction with our continuing focus on managing operating expenses, we continue to make meaningful progress in our goal for Streamline Health to become a world-class healthcare information technology company."

* Non-GAAP Financial Measures
Streamline Health reports its financial results in accordance with generally accepted accounting principles in the United States ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that these measures provide useful supplemental information regarding the performance of Streamline Health's business operations.

Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, and stock-based compensation expense.  A table illustrating this measure is included in this publication.

Conference Call Information
Streamline Health will conduct a conference call and webcast to review the results of the first quarter of fiscal 2012 today, June 7, 2012, at 11:00 a.m. ET.

Interested parties can access the call by dialing 877-407-8037, or listen via a live Internet webcast, which can be found at www.streamlinehealth.net or http://www.investorcalendar.com/IC/CEPage.asp?ID=168741.

In addition, a replay of the conference call will be archived and available until June 29, 2012 at the following number: 877-660-6853, account number: 396 and then conference ID: 395382.

About Streamline Health
Streamline Health provides solutions that help hospitals and physician groups improve efficiencies and business processes across the enterprise to enhance and protect revenues. Our enterprise content management solutions transform unstructured data into digital assets that seamlessly integrate with disparate clinical, administrative, and financial information systems. Our business analytics solutions provide real-time access to key performance metrics that enable healthcare organizations to identify and manage opportunities to maximize financial performance. Our integrated workflow systems automate and manage critical business activities to improve organizational accountability to drive both operational and financial performance. Across the revenue cycle, our solutions offer a flexible, customizable way to optimize the clinical and financial performance of any healthcare organization. For more information visit www.streamlinehealth.net.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell Streamline Health products, the ability of Streamline Health to control costs, availability of products produced from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which Streamline Health operates and nationally, and Streamline Health's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management's analysis only as of the date hereof. Streamline Health undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Financial Tables on Following Pages

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

  Cost of maintenance and support

  Selling, general and administrative

  Product research and development

  Miscellaneous income (expense)

Earnings (loss) before income taxes

Basic net earnings (loss) per common share

Number of shares used in basic per common share computation

Diluted net earnings (loss) per common share

Number of shares used in diluted per common share computation

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

Assets

  Accounts receivable, net of allowance for doubtful

    accounts of $100,000 and $100,000, respectively

  Prepaid hardware and third party software for future delivery

  Prepaid client maintenance contracts

  Office furniture, fixtures and equipment

  Accumulated depreciation and amortization

 Contract receivables, less current portion

 Capitalized software development costs, net of accumulated

   amortization of $­­­15,447,914 and $14,805,236, respectively

 Other, including deferred income taxes of $711,000, respectively

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

Liabilities and Stockholders' Equity

  Current portion of deferred revenues

  Contingent consideration for earn-out

  Lease incentive liability, less current portion

  Convertible redeemable preferred stock, $.01 par value
per share, 5,000,000 shares authorized, no shares issued

  Common stock, $.01 par value per share, 25,000,000
shares authorized, and 10,433,716 shares issued and
outstanding, respectively

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Three Months Ended April 30,
(Unaudited)

  Adjustments to reconcile net earnings (loss) to net cash

    provided by (used in) operating activities:

    Stock-based compensation expense

  Change in assets and liabilities:

    Accounts, contract and installment receivables

  Net cash provided by (used in) operating activities

  Purchases of property and equipment

  Capitalization of software development costs

  Net cash used in investing activities

  Net change under revolving credit facility

 Payments on capital lease obligation

  Net cash provided by financing activities

Increase (decrease) in cash and cash equivalents

Cash and cash equivalents at beginning of period

Cash and cash equivalents at end of period

Supplemental cash flow disclosures:

STREAMLINE HEALTH SOLUTIONS, INC.
Backlog
(Unaudited)
Table A

Streamline Health proprietary software

Hardware and third party software

STREAMLINE HEALTH SOLUTIONS, INC.
Bookings
(Unaudited)
Table B

Streamline Health Software licenses

Hardware & third party software

STREAMLINE HEALTH SOLUTIONS, INC.
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
Table C

This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health's management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, Streamline Health believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the company's current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company's management compensates for these limitations by considering the company's financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release.

Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands)

Adjusted EBITDA Reconciliation

    Amortization of capitalized software  development  costs  

    Amortization of intangible assets

    Stock-based compensation expense

Adjusted EBITDA per diluted share

Earnings (loss) per share - diluted

Adjusted EBITDA per adjusted diluted share

Diluted weighted average shares

    Includable incremental shares – adjusted EBITDA(1)

(1) The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed. If negative adjusted EBITDA is incurred, no additional incremental shares are assumed for adjusted diluted shares.

Visit our web site at: www.streamlinehealth.net

View the original article here

Heritage Health Solutions, Inc. Announces New President

Thu, May 31, 2012, 9:37 AM EDT - U.S. Markets close in 6 hrs 23 mins

Sorry, I could not read the content fromt this page.

View the original article here

Health 2.0 Developer Challenge Awards $1 Million for Innovative Health Care Solutions

BOSTON, MA--(Marketwire -05/14/12)- Health 2.0 announced today that it has awarded more than $1 million to health care innovators through its Developer Challenge series. The challenges, sponsored by both public and private entities such as the Office for the National Coordinator for Health Information Technology (ONC), Novartis, the Robert Wood Johnson Foundation, and Walgreens, bring multidisciplinary teams of developers together to address a specific, real-world health care issue.

Challenges run anywhere from one day to a number of months, giving sponsors unprecedented access to hundreds of talented developers focused on producing innovative solutions that can be quickly brought to market. Winning teams are awarded cash prizes up to $100,000 and often reinvest it into innovation, developing additional health solutions.

On May 14, 2012, at the Health 2.0 Spring Fling: Matchpoint Boston Conference, Farzad Mostashari, M.D., National Coordinator for Health Information Technology, joined Health 2.0 to award its millionth dollar for innovation.

"Sponsors always walk away with fresh perspectives, concepts, or working prototypes. It's a proven way to harness the creativity of the developer community and fast track an innovation to improve health care delivery for both physicians and patients," explained Health 2.0 Co-chair and CEO Indu Subaiya.

Since the program launch in 2010, Health 2.0 has completed 40 Developer Challenge events. In 2012, Health 2.0 will conduct more than 30 challenges worldwide, including events in Japan, Sweden and India.

The next Developer Challenge event, Washington DC's HDI Code-a-thon: Preventing Obesity, will be held June 2-3 at the Kaiser Permanente Center for Total Health. The coding competition challenges developers to use big data to build applications preventing obesity and ultimately improving health care.

For more information on the Health 2.0 Developer Challenge or to sponsor a challenge, contact Senior Vice President, Jean-Luc Neptune, at jl@health2con.com or at (646) 734-2320.

About Health 2.0
Health 2.0: The conference. The media network. The innovation community. The Health 2.0 Conference is the leading showcase of cutting-edge innovation transforming the health care system and is the premiere platform connecting IT innovators to established health care providers. Health 2.0 covers the broadest spectrum of the technology revolution that is shaking up every sector of health care. Learn more at www.health2con.com.

View the original article here

Catalyst Health Solutions Reports First Quarter 2012 Financial Results

ROCKVILLE, Md.--(BUSINESS WIRE)--

Catalyst Health Solutions, Inc. (NASDAQ: CHSI - News), today announced its financial results for the first quarter ended March 31, 2012.

First Quarter 2012 Highlights:

Revenue increased 29.7% to $1.45 billion Adjusted earnings per diluted share increased 19.2% to $0.62 GAAP earnings per diluted share were $0.39 Announced a PBM services contract with Regence Rx to manage 1.2 million lives, effective May 1, 2012 Extended agreements with WellCare and Michigan Public School Employees Retirement System Selected to provide prescription drug discounts to AARP members Added to Mercer Pharmacy Collective, a group purchasing service Executed a $4.4 billion merger agreement with SXC Health Solutions on April 17, 2012

“We are pleased with the performance of our business in the first quarter,” stated David T. Blair, Chairman and Chief Executive Officer of Catalyst.

“We look forward to completing the merger with SXC Health Solutions in the second half of 2012. This transaction will create significant benefits for our clients through a broader range of product offerings, more effective cost management, and increased investment in innovative programs and technologies,” added Blair.

First Quarter Results

Revenue for the first quarter of 2012 increased by $333 million, or 29.7%, to $1.45 billion from $1.12 billion for the first quarter of 2011. The increase in revenue is due to additional prescription volume from Catalyst Rx Health Initiatives, Inc. (CHI), formerly Walgreens Health Initiatives, initiation of services with new PBM clients, and price inflation on brand drugs, offset by client attrition, higher generic utilization, and the impact of higher member copayments due to the annual reset of plan deductibles.

Total prescription volume, after adjusting for the difference in days supply between 90-day prescriptions (mail and retail) and traditional 30-day retail prescriptions, was up 22.9% to 30.7 million for the quarter compared to 24.9 million for the same period in 2011, excluding administrative services only (ASO) claims. ASO claims increased significantly with the acquisition of CHI to 22.8 million in the first quarter of 2012 from 0.1 million in the prior year period. Due to the limited nature of services or contractual responsibilities, ASO claims are accounted for on a net basis in revenue. Adjusted mail-order penetration decreased to 9% from 11% in first quarter 2011 due to the change in mix with the CHI client base included in this year’s first quarter volume but not included in last year’s volume. Generic utilization increased to 76% in the first quarter of 2012 from 74% in the first quarter of last year.

Gross profit for the first quarter increased $33.7 million, or 54.8%, to $95.3 million from $61.6 million for the first quarter last year. The increase in gross profit was due to the addition of CHI, margin contribution from new clients, improved retail pharmacy economics, and generic utilization, offset by lower margins on renewal business, client attrition, and startup costs associated with Script Relief, our direct-to-consumer joint venture established in December of 2011. Gross profit is reported net of $4.2 million of acquisition related intangible asset amortization in the first quarter of 2012 and $1.8 million in the first quarter of 2011.

Selling, general and administration (SG&A) expenses for the first quarter of 2012 were $67.7 million, compared to $27.5 million for the first quarter last year. The increase in SG&A reflects investments Catalyst is making in growth including the CHI acquisition, our Invest Now initiative, IT infrastructure improvements and Script Relief. Additionally, we incurred $6.6 million in transaction and implementation costs associated with the Regence Rx contract award, the acquisition of an EGWP insurance company and non-recurring Medicare Part D plan set-up and administration costs. SG&A also includes CHI transition and integration expenses of $8.8 million and acquisition related intangible amortization of $5.7 million for the first quarter of 2012 versus $1.5 million and $1.5 million, respectively in the first quarter of 2011.

Adjusting for CHI transaction, transition and integration expenses and acquisition related intangible amortization, operating income increased by 19% to $46.3 million in the first quarter of 2012, from $38.9 million in the first quarter of 2011.

The effective tax rate of 37.8% in the first quarter of 2012 was lower than the effective tax rate of 38.4% in the comparable period in 2011 primarily due to a reduction in our state effective rate caused by the lower tax rate associated with the CHI business and the tax impact of Script Relief.

First quarter 2012 net income includes a non-controlling interest adjustment related to Script Relief. Due to the amount of control that Catalyst has over the joint venture, accounting rules require that the company consolidate the entity in its GAAP financial statements and remove the non-controlling interest income/(loss) from net income, which in the first quarter was ($3.4) million.

Net income attributable to Catalyst for the first quarter of 2012 was $19.2 million, or $0.39 per diluted share, compared to net income of $20.3 million, or $0.45 per diluted share, for the first quarter of 2011. Adjusting for CHI transaction, transition and integration expenses and acquisition related intangible amortization, net income per diluted share attributable to Catalyst increased by 19.2% to $0.62, from net income per diluted share of $0.52 in the first quarter of 2011.

“2012 is off to a great start with the Regence Rx agreement,” stated Richard A. Bates, President and Chief Operating Officer of Catalyst. “We continue to see RFP activity running substantially higher than last year’s selling season, with strong prospects in large employers, governments, and managed care organizations. Additionally, the integration of CHI is on track and we expect to achieve our stated financial goals,” added Bates.

Proposed Merger

On April 18, 2012, Catalyst Health Solutions, Inc. and SXC Health Solutions Corp announced that their Boards of Directors have unanimously approved a definitive merger agreement under which SXC and Catalyst will combine in a cash and stock transaction valued at approximately $4.4 billion. Under the terms of the agreement, Catalyst shareholders will receive $28.00 in cash and 0.6606 shares of SXC stock for each Catalyst share. The merger, which is subject to approval by SXC and Catalyst shareholders, U.S. antitrust approval, and other customary closing conditions, is expected to close in the second half of 2012.

Financial Guidance

In the proposed merger announcement issued on April 18, 2012, Catalyst reaffirmed its full-year 2012 revenue and adjusted EPS guidance, excluding costs related to the proposed merger with SXC.

About Catalyst Health Solutions, Inc. (www.chsi.com):

Catalyst Health Solutions, Inc., the fastest growing national PBM in the U.S., is built on strong, innovative principles in the management of prescription drug benefits and provides an unbiased, client-centered philosophy resulting in industry-leading client retention rates. The Company's subsidiaries include Catalyst Rx, a full-service pharmacy benefit manager (PBM) serving more than 18 million lives in the United States and Puerto Rico; HospiScript Services, LLC, one of the largest providers of PBM services to the hospice industry; FutureScripts, LLC, a full-service PBM serving approximately one million lives in the mid-Atlantic region; and a fully integrated prescription mail service facility. The Company's clients include self-insured employers, including state and local governments, managed care organizations, unions, hospices, third-party administrators and individuals.

Non-GAAP Financial Information

This press release includes certain non-GAAP financial information as defined by Securities and Exchange Commission Regulation G. Pursuant to the requirements of this regulation, reconciliations of this non-GAAP financial information to Catalyst Health Solutions, Inc. financial statements as prepared under generally accepted accounting principles (GAAP) are included in this press release. Catalyst’s management believes providing investors with this information gives additional insights into its results of operations. While Catalyst’s management believes that these non-GAAP financial measures are useful in evaluating its operations, this information should be considered as supplemental in nature and not as a substitute for the related financial information prepared in accordance with GAAP.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995 and within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. We use words such as "anticipates," "believes," "plans," "expects," "projects," "future," "intends," "may," "will," "should," "could," "estimates," "predicts," "potential," "continue," "guidance" and similar expressions to identify these forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements are not historical facts, but rather are based on our current expectations, estimates, assumptions and projections about the business, trends in the pharmacy benefit management ("PBM") industry, and developments in the legal, regulatory and economic environment. Accordingly, you should not place undue reliance on any such statements. In addition, our actual results may vary materially from those anticipated in such forward-looking statements as a result of many factors, many of which are beyond our control, and we cannot guarantee that our performance will be consistent with such forward-looking statements. We believe that these factors include, but are not limited to, the following:

Competition in the PBM industry is intense and could impair our ability to attract and retain clients; Our failure to anticipate and appropriately adapt to changes in the rapidly changing health care industry; The loss of one or more key network pharmacies impairing the competitiveness of our services; From time to time we engage in transactions to acquire other companies or businesses and if we are unable to effectively integrate or manage acquired businesses, our operating results may be adversely affected; A failure in the security or stability of our technology infrastructure, or the infrastructure of one or more of our key vendors, or a significant failure or disruption in service within our operations or the operations of such vendors; Our failure to execute on, or other issues arising under, key client contracts upon which our continued financial growth and profitability are dependent; If we or our suppliers fail to comply with complex and evolving laws and regulations, we could suffer penalties, be required to pay substantial damages and/or make significant changes to our operations; Changes in applicable laws or regulations, or their interpretation or enforcement, or the enactment of new laws or regulations, which apply to our business practices (past, present or future) or require us to spend significant resources in order to comply; Healthcare reform and other government efforts to reduce healthcare costs and alter healthcare financing practices could lead to a decreased demand for our services or to reduced profitability; Changes relating to Medicare Part D impairing our ability to market services to Medicare Part D eligible plans or members; Changes in industry pricing benchmarks could adversely affect our financial performance; and The terms and covenants relating to our existing indebtedness, our credit ratings and profile, or the future level of our indebtedness could adversely impact our financial performance and liquidity.

The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein and elsewhere, including the risk factors included in Catalyst Health Solutions, Inc.'s most recent reports on Form 10-K and Form 10-Q and other documents of Catalyst Health Solutions, Inc. on file with the Securities and Exchange Commission ("SEC"). Any forward-looking statements made in this material are qualified in their entirety by these cautionary statements, and there can be no assurance that the actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, us or our business or operations.

Transaction Forward-Looking Statements

In addition, numerous factors could cause actual results with respect to the proposed merger with SXC to differ materially from those in the forward-looking statements, including without limitation, the possibility that the expected efficiencies and cost savings from the proposed merger will not be realized, or will not be realized within the expected time period; the risk that the SXC and Catalyst businesses will not be integrated successfully; the ability to obtain governmental approvals of the proposed merger on the proposed terms and schedule contemplated by the parties; the failure of shareholders of SXC or Catalyst to approve the proposed merger; disruption from the proposed merger making it more difficult to maintain business and operational relationships; the risk of customer attrition; the possibility that the proposed merger does not close, including, but not limited to, due to the failure to satisfy the closing conditions; and the ability to obtain the financing contemplated to fund a portion of the consideration to be paid in the proposed merger and the terms of such financing.

Important Additional Information

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. The proposed merger will be submitted to the shareholders of Catalyst and the shareholders of SXC for their consideration. In connection therewith, the parties intend to file relevant materials with the SEC, including a joint proxy statement/prospectus that will be mailed to shareholders. Such documents, however, are not currently available. BEFORE MAKING ANY VOTING OR INVESTMENT DECISIONS, INVESTORS AND SECURITY HOLDERS OF CATALYST AND/OR SXC ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED MERGER AND ANY OTHER RELEVANT DOCUMENTS THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER. Investors and security holders may obtain free copies of the proxy statement/prospectus and other documents containing important information about Catalyst and SXC, once such documents are filed with the SEC, through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by SXC will be available free of charge on SXC's website at www.sxc.com under the heading "Investor Information" or by contacting SXC's Investor Relations Department at 630-577-3100. Copies of the documents filed with the SEC by Catalyst will be available free of charge on Catalyst's website at www.catalysthealthsolutions.com under the heading "Investor Information" or by contacting Catalyst's Investor Relations Department at 301-548-2900.

SXC, Catalyst and certain of their respective directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed merger. Information about the directors and executive officers of SXC is set forth in its proxy statement for its 2012 annual meeting of stockholders, which was filed with the SEC on April 2, 2012. Information about the directors and executive officers of Catalyst is set forth in its proxy statement for its 2012 annual meeting of shareholders, which was filed with the SEC on April 25, 2012. These documents can be obtained free of charge from the sources indicated above. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the joint proxy statement/prospectus and other relevant materials to be filed with the SEC when they become available.

View the original article here

Credit Repair Answers | Credit Solutions

http://creditservice.pro/ - 972-265-4378

Like us on Facebook at: http://www.facebook.com/karenrichardsbroker

Credit Repair answers that you have been looking for! If you are having credit challenges and need some help with credit repair, our knowledgeable staff is here to help. We are the credit sanitizing solution you need at a price you can afford!

View the original article here

Regence Rx and Catalyst Health Solutions Announce Pharmacy Benefit Management Agreement Through 2017

Mon, Mar 19, 2012, 10:54 PM EDT - U.S. Markets closed

Sorry, I could not read the content fromt this page.

View the original article here

Dovetail Health Selects Program Members Using DST Health Solutions' CareAnalyzer with Johns Hopkins ACGs to Achieve ...

BIRMINGHAM, Ala., March 13, 2012 /PRNewswire/ -- DST Health Solutions, LLC, today announced the availability of a new case study highlighting the implementation and success of its CareAnalyzer system at Dovetail Health, a Needham, Mass.-based health care organization designed to provide critical support to high-risk patients at home. The report, entitled "Dovetail Health Prevents Re-Admissions in High-Risk Patients Using CareAnalyzer from DST Health Solutions," also features results from Dovetail's recent work with Health New England, including a reduction in Medicare Advantage readmissions by 36 percent annually.

(Photo: http://photos.prnewswire.com/prnh/20120313/DE68752LOGO )

Dovetail Health used DST's CareAnalyzer to refine the process of selecting high risk health plan members by leveraging John's Hopkins ACGs (Adjusted Clinical Groups) and health plan administrative data.  High risk plan members are then targeted for proactive case management and personalized treatment programs. 

"High-risk patients represent an enormous financial obstacle for health plans," said Jeffrey Oberg, Director of Account Management, Dovetail Health.  "That's why we work with health plans to identify patients with a high likelihood of returning to the hospital and then implement programs that stabilize and manage patients at home, keeping them out of the hospital."   

As referenced in the case study, Dovetail Health uses DST's CareAnalyzer analytics to identify members at risk for adverse health outcomes after hospitalization.  Industry research suggests that as much as two-thirds of adverse events that occur post-discharge are a result of medication issues.  To mitigate these risks, Dovetail Health sends a clinical pharmacist into high-risk patients' homes to review medication therapies, identify potential interactions, and educate the patient on the importance of adherence.  In addition, patients receive personalized chronic illness coaching to help them more effectively partner with the health plan and their doctors to better manage their own health.

The care coordination promoted by this program positively impacts both the cost and quality of care. Readmissions account for approximately 16 percent of patients discharged, and cost an average of $6,000 to $10,000 per readmission. Patient safety is improved as are health outcomes resulting from the clinical review of the medication therapy combined with the promotion of patient education and engagement.  

"The majority of patients in our program have significant medication reconciliation and medication adherence issues," says Lara Terry, M.D., Medical Director for Dovetail Health. "This is a population where investing in more services and highly personalized interventions makes sense for both the health plan and the member." 

"DST Health Solutions is proud to be part of the Dovetail Health transition management program provided to Health New England's members, and of the positive impact of DST's CareAnalyzer to measure and reduce clinical and financial risk," said Steve Sabino, President of DST Health Solutions. "We believe the use of this analytical solution is resulting in significant gains in the quality of patient care and an efficiency to provide that care."

To order a PDF of the case study, "Dovetail Health Prevents Re-Admissions in High-Risk Patients Using CareAnalyzer from DST Health Solutions," click here.

About Dovetail Health
With a sole focus on preventing readmissions among the highest risk patients, Dovetail Health is a leading provider of transitional care services. Combining unique in-home pharmacist care managers with comprehensive infrastructure and customized technology systems, Dovetail has delivered reductions in readmissions for its health plan, provider group and hospital partners. For more information, contact Dana McNally at dmcnally@dovetailhealth.com or visit www.dovetailhealth.com.

About DST Health Solutions
DST Health Solutions, LLC delivers systems and services that help improve efficiency, reduce operational costs, increase speed to market, and facilitate medical cost management and price containment. Our clients include commercial health plans, consumer-directed plans, government plans (Medicare Advantage, Medicare Part D and Medicaid) and physician practices. DST Health Solutions' enterprise applications and outsourcing services include claims processing, member and provider management, benefit plan management, new product development, care management and medical management, and decision support/analytics. DST Health Solutions is a wholly-owned subsidiary of DST Systems, Inc. For more information about DST Health Solutions, contact 800.272.4799, email inforequests@dsthealthsolutions.com or visit www.dsthealthsolutions.com.

The information and comments above may include forward-looking statements respecting DST and its businesses. Such information and comments are based on DST's views as of today, and actual actions or results could differ. There could be a number of factors affecting future actions or results, including those set forth in DST's latest periodic financial report (Form 10-K or 10-Q) filed with the Securities and Exchange Commission. All such factors should be considered in evaluating any forward-looking comment. The Company will not update any forward-looking statements in this press release to reflect future events.

View the original article here

SXC Health Solutions 4Q net income jumps

LISLE, Ill. (AP) — SXC Health Solutions Corp. said Thursday that its net income soared 61 percent in the fourth quarter as both pharmacy benefit management and health care information technology revenue improved.

The Lisle, Ill., company also provided 2012 earnings and revenue outlooks above Wall Street's expectations.

Shares of SXC jumped $4.20, or 6.6 percent, to $67.73 in midday trading. Earlier in the session, the stock hit a new 52-week high of $68.74.

In the fourth quarter, SXC earned $26.7 million, or 42 cents per share. That's up from $16.6 million, or 26 cents per share, a year earlier.

Taking out amortization of intangible assets and other items, earnings were 48 cents per share, matching the average analyst estimate, according to a survey by FactSet.

Revenue for the three months ended Dec. 31 more than doubled to $1.38 billion from $526.9 million.

Wall Street forecast $1.27 billion in revenue.

Prescription benefit management revenue rose on acquisitions, higher prescription claim volumes due to new customers and converting customers from health care information technology to prescription benefit management contracts.

Health care information technology revenue climbed on higher transaction processing revenue and an increase in professional services work.

For the year, SXC earned $91.8 million, or $1.46 per share. That compares with earnings of $64.7 million, or $1.03 per share, in the previous year. Adjusted earnings were $1.63 per share.

Annual revenue more than doubled to $4.98 billion from $1.95 billion.

Looking ahead, SXC expects 2012 adjusted earnings of $2.37 to $2.45 per share on revenue of $6.8 billion to $6.9 billion.

Analysts forecast earnings of $2.31 per share on revenue of $6.51 billion.

View the original article here

Medco Health Solutions 4Q profit climbs 12 percent

Medco Health Solutions Inc.'s fourth-quarter net income rose 12 percent, as gains from generic prescriptions and the pharmacy benefits manager's specialty business helped offset costs from its pending acquisition by Express Scripts Inc.

A generic version of the cholesterol fighter Lipitor added about 3 cents per share to the Franklin Lakes, N.J., company's earnings. Lipitor, the world's top selling drug, lost its patent protection late in the fourth quarter.

Medco said Tuesday its generic dispensing rate climbed 2.5 percentage points in the quarter to 74.7 percent of total prescription volume. Generic drugs are less expensive than their brand-name counterparts, so they can hurt revenue for pharmacy benefits managers, or PBMs, but improve profit margins.

Overall, Medco reported net income of $424.4 million, or $1.08 per share, in the quarter ended Dec. 31. That compares to $378.5 million, or 88 cents per share, in the final quarter of 2010.

Revenue also climbed 12 percent to almost $19 billion. The latest quarter had an extra week compared to the 2010 quarter.

Adjusted earnings excluding costs tied to the Express Scripts deal and other expenses amounted to $1.25 per share.

The performance topped Wall Street expectations. Analysts surveyed by FactSet expected, on average, earnings of $1.17 per share on $17.38 billion in revenue.

PBMs process mail-order prescriptions and handle bills for prescriptions filled at retail pharmacies, acting as middlemen between employers offering prescription drug benefits and drugmakers.

Medco's adjusted prescriptions — which count 90-day mail order prescriptions as three 30-day prescriptions — rose 7.7 percent in the quarter to 263.1 million.

Revenue from Medco's Accredo specialty pharmacy business climbed 28 percent to $3.8 billion on growth in multiple sclerosis, rheumatoid arthritis, oncology and hepatitis prescriptions. Accredo distributes drugs that require special handling, including treatments for chronic illnesses.

BMO Capital Markets analyst Dave Shove said in a research note Medco's prescription volumes came in better than he expected across all categories.

The company also reported $43.6 million in expenses related to Express Scripts in the fourth quarter, mostly due to legal fees and employee retention-related expenses.

Last July, St. Louis-based Express Scripts announced a $29.1 billion deal to buy Medco, a combination that would create a company that handles the prescriptions of about 135 million people, or more than one in three Americans.

Shareholders from both companies have approved the deal, and Medco said Tuesday it remains confident the acquisition will close in the first half of this year.

Medco agreed to the deal after reporting a string of major contract losses. But Chairman and CEO David B. Snow Jr. told analysts Tuesday the latest quarterly results show that his company will combine with Express Scripts from a position of strength.

For the full year, Medco reported net income of $1.46 billion, or $3.62 per share, on about $70.1 billion in revenue.

Medco expects 2012 revenue to fall about 16 percent to $58.9 billion, which matches analyst forecasts. Starting this year, Medco no longer handles prescription drug benefits for the California Public Employees' Retirement System, MemberHealth LLC, Bravo Health, and the mail order prescription benefit of the Federal Employees Health Benefits Program.

The company also expects generic drugs to reduce revenue by about $6.5 billion.

Medco shares fell 31 cents to $63.70 in trading Tuesday morning while broad market indexes rose slightly.

View the original article here

Castlight Health Strengthens Management Team to Capitalize on Growing Demand for Health Care Transparency Solutions

Fri, Feb 17, 2012, 8:16 AM EST - U.S. Markets open in 1 hr 14 mins

Sorry, I could not read the content fromt this page.

View the original article here

The Nebraska Medical Center Expands Use of Streamline Health Content Management Solutions

CINCINNATI, Feb. 2, 2012 /PRNewswire/ -- Streamline Health Solutions, Inc. (NasdaqCM: STRM - News), a leading provider of enterprise content management and business analytics solutions for healthcare organizations, today announced that The Nebraska Medical Center will expand its use of Streamline Health's content management solutions through a direct licensing agreement with the Company. The medical center is migrating to a direct license with the Company from a license through a Streamline Health strategic partner.

The Nebraska Medical Center is Nebraska's largest healthcare facility, employing more than 4,900 employees and with over 1,000 physicians in all major specialties and sub-specialties on staff. The medical center has successfully utilized Streamline Health's AccessAnyWare® and FolderAnyWare content management solutions and HIM workflows in its Health Information Management and Patient Financial Services departments since 2006. As part of the new agreement the medical center will continue to license these solutions and will also add Streamline Health's Integration Suite for Epic EMR. The Integration Suite will allow for seamless access to scanned patient information within the Epic electronic medical record system, providing physicians and staff in multiple departments with instant access to critical information.

"Our Company's growth and the ongoing development of our solutions are reflected in our clients' expanding use of our solutions," said Robert E. Watson, president and chief executive officer of Streamline Health. "The Nebraska Medical Center is a valued client and we are pleased that it has chosen a direct license with Streamline Health. By utilizing our Integration Suite with its EMR, the medical center will have an even more powerful system to help staff access information and continue to provide the level of care the medical center is known for."

About Streamline Health

Streamline Health provides solutions that help hospitals and physician groups improve efficiencies and business processes across the enterprise to enhance and protect revenues. Our enterprise content management solutions transform unstructured data into digital assets that seamlessly integrate with disparate clinical, administrative, and financial information systems. Our business analytics solutions provide real-time access to key performance metrics that enable healthcare organizations to identify and manage opportunities to maximize financial performance. Our integrated workflow systems automate and manage critical business activities to improve organizational accountability to drive both operational and financial performance. Across the revenue cycle, our solutions offer a flexible, customizable way to optimize the clinical and financial performance of any healthcare organization. For more information visit www.streamlinehealth.net.

About The Nebraska Medical Center

With a reputation for excellence, innovation and extraordinary patient care, The Nebraska Medical Center has earned J.D. Power and Associates' Hospital of Distinction award for inpatient services for six consecutive years. It also received the 2011 Consumer Choice Award, a mark of patient satisfaction as selected by healthcare consumers and has achieved Magnet recognition status for nursing excellence. As the teaching hospital for the University of Nebraska Medical Center, this 624 licensed bed academic medical center has an international reputation for providing solid organ and bone marrow transplantation and is well known nationally and regionally for its oncology, neurology and cardiology programs.  The Nebraska Medical Center can be found online at www.nebraskamed.com.

Epic is a registered trademark of Epic Systems Corporation.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties and are no guarantee of future performance. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company's products, the ability of the Company to control costs, availability of products obtained from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Director of Marketing Communications

View the original article here

Health Endeavors and Aviacode Partnership Expands Compliance Solutions for Healthcare Organizations

Tue, Jan 24, 2012, 7:58 AM EST - U.S. Markets open in 1 hr 32 mins

Sorry, I could not read the content fromt this page.

View the original article here

Aegis Health Group Taps Technology to Expand Capabilities and Provide Solutions to Hospitals’ Business Development Needs

How to Play the 5 Big 'What Ifs' of 2012The Wall Street Journal

These five scenarios that could damage returns or lead to profit are keeping Wall Street awake at night

View the original article here

TELUS Health Solutions launches new Canadian health reference portal, myhealthreference.com

88 per cent of Canadians are looking for online health information with Canadian references, yet 72 per cent concerned about reliability*

MONTREAL , Jan. 19, 2012 /CNW/ - TELUS is making access to reliable, verified Canadian healthcare information online a snap with myhealthreference.com. myhealthreference.com, a new health reference internet portal, is designed to help Canadians find the relevant information and tools they need to take better care of their health and the health of their loved ones.

A recent national poll by Vision Critical found 72 per cent of Canadians are concerned with the reliability of healthcare information they find online, yet 53 per cent still use the Internet as their primary health information reference.

"Technology has empowered us with convenient, fast access to health information. Yet much of the online information is unverified. myhealthreference.com will allow Canadians to quickly find credible, reliable and expert-reviewed health information for themselves and their families," said Paul Lepage , senior vice-president, TELUS Health Solutions.

With 66 per cent of Canadians seeking a single point for online health information, the new site will deliver current content, reviewed articles and specialized functions to make the consumer experience "future friendly".

The new site includes access to:

Web and mobile tools such as a symptom checker, self-assessment modules, healthy habits guides and smoking cessation programs Powerful search feature that "learns" from user trends and health news to deliver relevant, credible content to returning visitors Reliable reference content and news from trusted Canadian sources covering health topics from A to Z Advice from physicians, pharmacists, naturopaths and nutritionists, as well as information to find specialized local resources

The Vision Critical survey also reveals:

90 per cent of women identified themselves as the primary health seekers in the family 70 per cent of mothers first look to the Internet to gather health advice for their children 94 per cent of mothers prefer a website with information from a Canadian reference 66 per cent of Canadians have used online health information for positive results 25 per cent of Quebecers do not have a family physician. The highest rate from all provinces surveyed (17% BC, 14% AB, 8% MB/SK, 10% ON, 13% ATL) 33 per cent of Canadians over 55 say it's difficult to find dietary tips for specific chronic health conditions

To explore the new site go to www.myhealthreference.com.

*The Vision Critical poll of 1,500 Canadians was conducted from December 19 to December 22, 2011 .

About TELUS Health Solutions
TELUS Health Solutions is a leader in telehealth, electronic health records, remote patient monitoring, mobile home and community care, consumer health, benefits management and pharmacy management. Our solutions give health authorities, providers, primary care physicians, patients and consumers the power to enhance decision making and improve outcomes for Canadians. TELUS Health Solutions is transforming how information is used across the continuum of care from hospital to home with solutions that foster collaboration, drive prevention and empower care teams and patients. TELUS Health Solutions is Canada's leading Healthcare IT Company as cited by the Branham Group for five years and for being honoured as the ITAC Health Company of the Year (2008) and Health Transformation Company of the Year (2009). For more information about TELUS Health Solutions, please visit www.telushealth.com and www.telushealthspace.com.

About TELUS
TELUS (TSX: T, T.A; NYSE: TU) is a leading national telecommunications company in Canada , with $10.3 billion of annual revenue and 12.6 million customer connections including 7.2 million wireless subscribers, 3.6 million wireline network access lines, 1.3 million Internet subscribers and more than 450,000 TELUS TV customers. Led since 2000 by President and CEO, Darren Entwistle , TELUS provides a wide range of communications products and services including data, Internet protocol (IP), voice, entertainment and video.

In support of our philosophy to give where we live, TELUS, our team members and retirees have contributed $245 million to charitable and not-for-profit organizations and volunteered 4.1 million hours of service to local communities since 2000. Eleven TELUS Community Boards across Canada lead TELUS' local philanthropic initiatives. TELUS was honoured to be named the most outstanding philanthropic corporation globally for 2010 by the Association of Fundraising Professionals, becoming the first Canadian company to receive this prestigious international recognition.

For more information about TELUS, please visit telus.com.

Survey Methodology
From December 19 to December 22, 2011 , Vision Critical conducted an online survey among a randomly selected, representative sample of 1,500 Canadians who are Vision Critical Forum panel members. Individuals were sampled according to Census data to be representative of the Canadian national adult population. The full dataset has been statistically weighted according to the most current gender, age, region (and in Quebec , language) Census data to ensure a sample representative of the entire adult population of Canada . The margin of error is ±2.7 per cent, 19 times out of 20. Discrepancies in or between totals are due to rounding.

View the original article here

Health Net Community Solutions Centers Offer Free Health and Wellness Activities to Local Communities They Serve

LOS ANGELES--(BUSINESS WIRE)-- As 2012 begins and we focus on our New Year’s resolutions, Health Net, Inc. (NYSE: HNT - News) wants to remind you that one of the best gifts we can give to ourselves is to help ourselves be healthy.

You are not alone if your New Year’s resolution includes improving your health. According to FC Organizational Products LLC, which annually publishes the top ten New Year’s resolutions, two of the top three New Year’s resolutions for 2012 are health related: 1. Become more physically fit; and 2. Improve one’s health.

In the spirit of kick-starting the New Year on a healthy note, Health Net’s Community Solutions Centers (CSC) offer a large variety of free fitness and health-related classes, activities and events every month. In fact, the centers provide these services and health education classes all year long to all local residents, both kids and adults, alike.

Examples of activities to participate in:

Fun Fitness for Kids, Adults and Seniors Zumba Exercise Class Educational classes on topics such as cancer, heart disease, etc. Support groups that deal with depression, alcoholism, etc. Meditation

In addition to these health-promoting classes, the CSCs also offer a full scope of free activities that extend beyond health and fitness. Using the expertise of local government agencies and local community groups, the centers provide activities ranging from educational classes on cancer and prevention (Fresno) to knitting beanies for cancer patients at a local children’s hospital (East Los Angeles) to passing out free bread to the local community (Stanislaus).

Adding these positive New Year’s resolutions into your daily routine is a great way to start the New Year and help maintain a healthy lifestyle. Getting involved in one’s own wellness is key to leading a healthy life and what better way to do it, while connecting with other members in your community.

Health Net is proud to offer these educational services and events to the communities it serves.

Community Solutions Center locations:

About Health Net of California

Health Net of California, Inc., a subsidiary of Health Net, Inc., is one of the largest health plans in the state. Together with Health Net Life Insurance Company, it serves more than 2.2 million members statewide and contracts with 67,000-plus physicians, 300-plus hospitals and 5,000-plus pharmacies, giving its members greater choice and more convenient access to care. For more information about Health Net, visit the website at www.healthnet.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50130887&lang=en

MULTIMEDIA AVAILABLE:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50130887&lang=en

View the original article here